May 26, 2020 Cellectar Receives FDA Fast Track Designation for CLR 131 in Lymphoplasmacytic Lymphoma/Waldenstrom’s Macroglobulinemia Learn More
May 7, 2020 Cellectar Reports First Quarter 2020 Financial Results and Provides a Corporate Update Learn More
Mar 9, 2020 Cellectar Reports Financial Results for Year Ended December 31, 2019 and Provides a Corporate Update Learn More